96 / 164
356
right descending pulmonary artery in 1.085 cases. Am J Roentgenol
1962;87:929-935.
19. Hachulla E, Gressin V, Gillevin L, Carpentier P, Diot E et al. Early
detectionof Pulmonary Arterial Hypertension in systemic Sclerosis, A
French nationwidw prospective study. Arthritis Rheum2005;52:3792-
3800
20. Gruning E, Wiessmann S, Ehlken N, Fijakowska A, Fisher C, et al. Stress
Doppler echocardiography in relatives of patients with idiophatic
and familial pulmonary aterial hypertension: Result of a multicenter
European analysis of pulmonary arterial hypertension pressure
response to exercise anh hypoxia. Circulation 2009;119:1747-1757
21. Fisher MR, Forfia PR, Chamera E, Housten-Harris T, Champions HC, et al.
Accuracy of Doppler Echocardiography in the hemodynamic assessment
of pulmonary hypertension. A Crit Care Med Resp 2009;179:615-621
22. McQuillan BM, Picard NH, Leavitt M, Weyman AE. Clinical Correlates
and reference intervals fo pulmonary artery systolic pressure among
echocardiography normal subjects. Circulation 2001; 104: 2797-
2802
23. Galie N, Corris P, Frost A, Girgis R, Granton J, Zhi Cheng Jing, klepetko W
et al. Update treatment algorithm of pulmonary arterial hypertension.
JACC 2013;62(25), Suppl D60-72
24. McLaughlin V, Gaine S, Howard L, Leuchte H, Mathier M, Mehta S,
Palazzini M et al :treatment goals of pulmonary hypertension. JAm Coll
Cardiol 2013; 62(25):D73-81
25. Sitbon et al. Long-term response to calcium channel blockers
in idiopathic pulmonary arterial hypertension. Circulation.
2005;111(23):3105-11.
26. Zagolin M et al. Vasorreactividad a adenosina en los pacientes con
hipertensión pulmonar arterial:Prevalencia y respuesta clínica,
funcional y hemodinámica al tratamiento con diltiazem. Rev Chil Enf
Respir 2009; 25: 8-14
27. Galie N., Muller K, Scalise AV., Grunig E. PATENT PLUS : A blinded
randomized an d extensión study of riociguat plus sildenafil in PAH. Eur
Resp J 2015; Feb 4; pii:ERJ_01059-2014 .
28. AmbitionFirst-Line Combination of Ambrisentan and Tadalafil Reduces
Risk of Clinical Failure Compared to Monotherapy in Pulmonary
Arterial Hypertension Outcomes Study . Presentado Congreso Europea
Enfermedades respiratorias. Munich septiembre 8, 2014.
29. Sitbon O., Jais X., Savale L., Cottin V et al.Upfront triple combination
therapy in pulmonary arterial hypertension: a pilot study Eur Respir J
2014;43 (6):1691- 97.
30. Krowka MJ, Swanson KL, Frantz RR, McGoon MD, Wiesner RH.
Portopulmonary hypertension: results from a 10-year screening
algorithm. Hepatology 2006; 44: 1502-10.
31. Trulock eP, Edwards LB, Taylor DO. Registry of the International
Society for Heart and Lung Transplantation report-2006.J Hear Lung
transplant 2006;25:880-92.
32. Toyoda Y, Thacker J, Santos R. Long-term outcome of lung and heart-
lung transplantation for idiopathic pulmonary arterial hypertension.
Ann Thorax Surg 2008;86:1116-22.
33. De Perrot M, Granton JT, McRae K. Outcome of patients with pulmonary
arterial hypertension referred for lung transplantation: a 14-year single
–center experience. J Thorac Cardiovasc Surg 2012;143:910-8.
[REV. MED. CLIN. CONDES - 2015; 26(3) 344-356]